Comparison
20p13 Microdeletion Syndrome C4750789 vs 16p11 2p12 2 Microduplication Syndrome C4518821
Clinical comparison between 20p13 Microdeletion Syndrome and 16p11 2p12 2 Microduplication Syndrome for differential diagnosis and treatment planning.
20p13 Microdeletion Syndrome C4750789
A genetic condition from missing genetic material at the tip of chromosome 20. Features may include developmental delay, speech difficulties, and distinctive facial features. Treatment involves developmental therapies and regular monitoring.
16p11 2p12 2 Microduplication Syndrome C4518821
A rare genetic condition involving extra genetic material on chromosome 16. It may affect development and be associated with developmental delays, learning difficulties, and distinctive features in some individuals. Management involves supportive therapies.
6 comparison axes
Onset
20p13 Microdeletion Syndrome C4750789
0-null
16p11 2p12 2 Microduplication Syndrome C4518821
0-null
Onset patterns differ
Severity
20p13 Microdeletion Syndrome C4750789
severe
16p11 2p12 2 Microduplication Syndrome C4518821
moderate
Different severity levels
Chronic
20p13 Microdeletion Syndrome C4750789
Chronic
16p11 2p12 2 Microduplication Syndrome C4518821
Chronic
Differing course
Communicable
20p13 Microdeletion Syndrome C4750789
No
16p11 2p12 2 Microduplication Syndrome C4518821
No
Different transmission
Body System
20p13 Microdeletion Syndrome C4750789
congenital
16p11 2p12 2 Microduplication Syndrome C4518821
congenital
Same/different system
Category
20p13 Microdeletion Syndrome C4750789
rare-disease
16p11 2p12 2 Microduplication Syndrome C4518821
genetic
Different category
Bottom line
20p13-microdeletion-syndrome-C4750789 and 16p11-2p12-2-microduplication-syndrome-C4518821 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 20p13 Microdeletion Syndrome C4750789 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Discriminating power |
|---|---|---|---|
| Genomic change | Missing material at the tip of chromosome 20 (20p13). | Extra material involving 16p11.2 to 16p12.2. | High |
| Development and learning | Developmental delay and speech difficulties are described. | Developmental delay and learning difficulties may occur in some people. | Moderate |
| Reported severity | Source severity is labeled severe, but individual course is not established. | Source severity is labeled moderate, with variable features. | Low |
When to favor each condition
Choose 20p13 Microdeletion Syndrome C4750789 when
A validated test shows a 20p13 deletion.
The diagnosis depends on the specific missing chromosomal region.
High
Speech delay is the main described concern.
Speech difficulty is specifically mentioned for the deletion.
Moderate
Counseling concerns a deletion rather than extra material.
Mechanism and recurrence discussion differ by copy-number type.
Moderate
Choose 16p11 2p12 2 Microduplication Syndrome C4518821 when
A validated test shows a 16p11.2p12.2 duplication.
The diagnosis requires extra material in that region.
High
Learning difficulty is reported without a confirmed deletion.
Learning difficulty is described for the duplication, but testing is required.
Moderate
Features are mild, absent, or variable.
The source states distinctive features occur in some individuals only.
Moderate
How key tests differ
| Test | 20p13 Microdeletion Syndrome C4750789 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss at 20p13. | Copy-number gain at 16p11.2–16p12.2. | This is the main way to distinguish the two findings; clinician review is required. |
| Standard karyotype | A microdeletion may not be visible. | A microduplication may not be visible. | A normal karyotype does not exclude either condition. |
| Parental copy-number testing | Inheritance pattern is not established here. | Inheritance pattern is not established here. | Parental results guide counseling but do not alone determine prognosis. |
Prognosis comparison
20p13 Microdeletion Syndrome C4750789
- Outcome
- Long-term outcome is not established; the source labels severity as severe.
- Factors
- Individual findings, developmental needs, and access to therapy may influence course.
16p11 2p12 2 Microduplication Syndrome C4518821
- Outcome
- Long-term outcome is not established; the source labels severity as moderate and features as variable.
- Factors
- Learning needs, variable physical findings, and supportive care may influence course.
Time frame: Both are lifelong congenital conditions; exact course is not established.
Prognosis requires clinician interpretation and should not be inferred from severity labels alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Delay and speech difficulty may require therapy. Delay and learning difficulty may require support. Specific complication rates are not established. |
| Physical or facial findings | Distinctive facial features are described. Distinctive features may be present in some people. Appearance alone cannot distinguish these conditions. |
| Medical complications | Organ-specific complications are not established from the source. Organ-specific complications are not established from the source. Monitoring should be individualized by a clinician. |
Patient education highlights
- HighConfirmation
Only a validated genetic test can distinguish deletion from duplication.
- HighSupportive care
Developmental, speech, and learning therapies are the described management approaches.
- MediumTransmission
Neither condition is communicable; inheritance should be discussed with a genetics clinician.